1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
  2. "Surgery"
  3. "David Jones"
  4. "William Travis"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Solid Tumor Oncology Division (8)
  5. Surgery (8)
  6. Thoracic Oncology (8)

More Groups

People
  1. Charles Rudin (8)
  2. David Jones (8)
  3. William Travis (8)
  4. Natasha Rekhtman (5)
  5. Bob Li (4)
  6. Maria Arcila (4)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (2)
  4. 2016 (2)
  5. 2015 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Discovery (1)
  3. Clinical Cancer Research (1)
  4. Journal of Thoracic Oncology (1)
  5. Laboratory Investigation (1)
  6. Modern Pathology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Nature Research (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Lebow, E. S.; Tu, H. Y.; Li, M.; Lim, L. P.; Arbour, K. C.; Travis, W.; Solit, D. B.; Ladanyi, M.; Jones, D. R.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
    Journal Article

    Rekhtman, N.; Montecalvo, J.; Chang, J. C.; Alex, D.; Ptashkin, R. N.; Ai, N.; Sauter, J. L.; Kezlarian, B.; Jungbluth, A.; Desmeules, P.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Lessons learned from next generation sequencing in use of immunohistochemistry (IHC) for EGFR L858R and ALK in lung cancer predictive testing
    Meeting Abstract

    Montecalvo, J.; Leduc, C.; Rekhtman, N.; Moreira, A.; Arcila, M.; Berger, M.; Rudin, C.; Rusch, V.; Jones, D.; Travis, W.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Lessons learned from next generation sequencing in use of immunohistochemistry (IHC) for EGFR L858R and ALK in lung cancer predictive testing
    Meeting Abstract

    Montecalvo, J.; Leduc, C.; Rekhtman, N.; Moreira, A.; Arcila, M.; Berger, M.; Rudin, C.; Rusch, V.; Jones, D.; Travis, W.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival
    Journal Article

    Ujiie, H.; Kadota, K.; Chaft, J. E.; Buitrago, D.; Sima, C. S.; Lee, M. C.; Huang, J.; Travis, W. D.; Rizk, N. P.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save